8/20/2024

Nafcillin Sodium Injection

Products Affected - Description

- Nafcillin sodium injection, Baxter, 1 gram/50 mL, premixed bag, 24 count, NDC 00338-1017-41 - discontinued
- Nafcillin sodium injection, Baxter, 2 gram/100 mL, premixed bag, 12 count, NDC 00338-1019-48
- Nafcillin sodium injection, Eugia US, 2 gram, vial, 10 count, NDC 55150-0123-15

Reason for the Shortage

- Armas has nafcillin injection available.
- Baxter did not provide a reason for the shortage. The 1 gram premixes have been discontinued.
- Eugia has nafcillin injection available.
- Fresenius Kabi has nafcillin injection available.
- Sagent has nafcillin injection available.
- Sandoz discontinued their nafcillin injection presentations.
- WG Critical Care has nafcillin injection available.

Available Products

- Nafcillin sodium injection, Armas Pharmaceuticals, 2 gram, vial, 10 count, NDC 72485-0406-10
- Nafcillin sodium injection, Eugia US, 1 gram, vial, 10 count, NDC 55150-0122-15
- Nafcillin sodium injection, Eugia US, 10 gram, vial, 1 count, NDC 55150-0124-99
- Nafcillin sodium injection, Fresenius Kabi, 1 gram, vial, 10 count, NDC 63323-0327-10
- Nafcillin sodium injection, Fresenius Kabi, 10 gram, vial, 1 count, NDC 63323-0330-60
- Nafcillin sodium injection, Fresenius Kabi, 2 gram, vial, 10 count, NDC 63323-0328-20
- Nafcillin sodium injection, Sagent, 10 gram, vial, 1 count, NDC 70860-0119-99
- Nafcillin sodium injection, WG Critical Care, 1 gram, vial, 10 count, NDC 44567-0221-10
- Nafcillin sodium injection, WG Critical Care, 2 gram, vial, 10 count, NDC 44567-0222-10

Estimated Resupply Dates

- Baxter has nafcillin 2 gram/100 mL premixed bags available via direct orders only.

Updated

Updated August 20, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 20, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.